Feb 24, 2026

Tesla (TSLA) Stock: The EU Numbers That Investors Can’t Ignore

TLDR Tesla EU registrations fell 17% in January to 8,075 units BYD registrations surged 165% to 18,242 units in the same period TS...

Feb 24, 2026

Amazon (AMZN) Stock: $12 Billion Louisiana Data Center Plan Explained

TLDR Amazon is investing $12 billion in data centers across northwest Louisiana, in Caddo and Bossier Parishes The project will cr...

Feb 24, 2026

IonQ Stock: Quantum Player Lands Spot on $151B Defense Contract

TLDR IonQ secured a spot on the Missile Defense Agency’s SHIELD IDIQ contract, which has a $151 billion ceiling. IonQ is one of mo...

Feb 24, 2026

Warner Bros (WBD) Stock: Paramount Skydance Raises Bid in Bidding War With Netfl...

TLDR Paramount Skydance raised its WBD bid above $30/share, likely exceeding $31 WBD’s board will review the offer but still recom...

Feb 24, 2026

Advanced Micro Devices (AMD) Stock: Meta Signs $100 Billion AI Chip Deal

TLDR Meta and AMD agreed to a deal worth over $100 billion for 6 gigawatts of AI computing power over five years. AMD will supply...

Feb 24, 2026

Cathie Wood Sells $35M in Teradyne, Moves Money Into Figma, AMD, Broadcom, and G...

TLDR ARK Invest sold ~$35.7M in Teradyne shares on February 23, 2026 ARK bought $12.46M in Figma stock after a 5.1% price drop AMD...

Feb 24, 2026

Daily Market Update: 5 Things Moving Crypto and Stock Markets Today — AI, Tariff...

TLDR Bitcoin is trading near $62,900, down 7.5% for the week, trapped in a $60K–$70K range ETH, XRP, SOL, and DOGE all fell 8–11%...

Feb 23, 2026

MSTR Stock Drops as Strategy Buys 592 Bitcoin for $39.8M

TLDR Strategy completed its 100th Bitcoin purchase with a 592 BTC acquisition worth about $39.8 million. The company increased its...

Feb 23, 2026

Domino’s Pizza (DPZ) Stock Rises on Strong Q4 Results and 14% Dividend Hike

TLDR U.S. same-store sales grew 3.7% in Q4, beating analyst estimates of 3.47% Revenue hit $1.54B, up 6.4% year-over-year and $20M...

Feb 23, 2026

Novo Nordisk (NVO) Stock Drops 15% After CagriSema Fails to Beat Eli Lilly’s Zep...

TLDR Novo Nordisk stock fell 15% after CagriSema failed to prove non-inferiority to Eli Lilly’s tirzepatide in an 84-week trial. C...